Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serum levels of intravenously and enterally administered moxifloxacin in critically ill ICU patients
2007-004941-13Phase 4Completed
- Sponsor
- University Hospital Tübingen
- Start
- Oct 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of moxifloxacin in Airways Infection and cutaneous infection (2 arms), sponsored by University Hospital Tübingen. Primary endpoint: Maximum serum concentration (Cmax) of moxifloxacin at steady state. Started Oct 2007; status: completed.
02
Drugs
moxifloxacin
03
Conditions
Airways Infectioncutaneous infection
Beyond the preview
Go deeper on 2007-004941-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004941-13.